Skip to content

A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00565006
Enrollment
22
Registered
2007-11-29
Start date
2006-07-31
Completion date
2006-09-30
Last updated
2015-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ambulatory Blood Pressure

Brief summary

This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Interventions

DRUGMK0859

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* You are between the ages of 45-75 * You are a man or non-pregnant woman * You agree to not eat or drink fruit or fruit juices (orange, apple or grapefruit) for 2 weeks before starting study medication

Exclusion criteria

* You have smoked or used other nicotine-containing products (chewing tobacco) within the last 6 months * You have used St. John's Wort or any products that include it within the last 2 weeks * You have used herbal, organic, dietary or nutritional remedies within the last 2 weeks * You have a history of drug allergies (anaphylaxis, angioedema) * You have taken an investigational drug in another clinical trial within the last 4 weeks * You have a history of cardiovascular disease including hypertension (high blood pressure) * You have a history of renal disease * You have a history of gall bladder disease or have had abnormal liver function tests * You have a history of drug or alcohol abuse * You drink more than 6 cups of caffeinated beverages a day (coffee, tea or cola)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026